Wallonia-BIOMED — HuMAb-S aureus — ULB (Q4026999)

From EU Knowledge Graph
Revision as of 21:18, 17 January 2022 by DG Regio (talk | contribs) (‎Created claim: summary (P836): Development of a research project in the field of therapeutic human monoclonal antibodies using S.aureus as a model., translated_summary)
Jump to navigation Jump to search
Project Q4026999 in Belgium
Language Label Description Also known as
English
Wallonia-BIOMED — HuMAb-S aureus — ULB
Project Q4026999 in Belgium

    Statements

    country
    Belgium
    0 references
    EU contribution
    180,642.94 Euro
    0 references
    budget
    451,607.35 Euro
    0 references
    co-financing rate
    40.0 percent
    0 references
    start time
    15 May 2014
    0 references
    end time
    31 December 2023
    0 references
    beneficiary name (string)
    U.L.B.
    0 references
    beneficiary
    Q4022834
    0 references
    programme
    Wallonia - ERDF
    0 references
    coordinate location

    50°49'32.34"N, 4°22'18.84"E
    0 references
    postal code
    1050
    0 references
    summary
    Développement d'un projet de recherche dans le domaine des anticorps monoclonaux humains à but thérapeutique utilisant le S.aureus comme modèle. (French)
    0 references
    Development of a research project in the field of therapeutic human monoclonal antibodies using S.aureus as a model. (English)
    point in time
    17 January 2022
    0 references

    Identifiers

    Belgian Kohesio ID
    WAL-873
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q4026999&oldid=23092479"